ArticleClinical case reports2019
Use of botulinum toxin in Frey's syndrome.
Article in Clinical case reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 23 citations in OpenAlex.
- Combined BTX-A and Collagen Membrane in Benign Parotid Enucleation: A Comparative Cohort Study.Craniomaxillofacial trauma & reconstruction · 2026Article
- Sonographic anatomy and imaging of the great auricular nerve.Surgical and radiologic anatomy : SRA · 2025Review
- Textural Analysis of Magnetic Resonance Images as an Additional Evaluation Tool of Parotid Glands in Sjögren-Primarily Findings.Biomedicines · 2023Article
- Review
- Utilities of Botulinum Toxins in Dermatology and Cosmetology.Clinical, cosmetic and investigational dermatology · 2021Review
- Pneumoparotid and Pneumoparotitis: A Literary Review.International journal of environmental research and public health · 2020Review
- Hyperbaric oxygen therapy in a case of cervical abscess extending to anterior mediastinum, with isolation ofBMJ case reports · 2019Article
- Use of botulinum toxin in Frey's syndrome.Clinical case reports · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Frey's syndrome is the most common adverse event after parotidectomy, and usually, it appears after 6 months. In our case, symptoms appear 20 years from surgery, an uncommon condition. Intralesional botulinum toxin gives excellent results in therapy, regardless of the time elapsed between surgery and the first treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.